Replies to post #313395 on Avid Bioservices Inc (CDMO)

[cjgaddy]

Was waiting on the next PPHM/Ronin/Shareholders to update, but I think it's time to add SITC'17 regardless...
See:
Nov8-12 2017: “(SITC) Society for Immunotherapy of Cancer 32nd Annual Meeting”, Natl-Harbor MD
http://investorshub.advfn.com/boards/manage_msg.asp?message_id=134756056

KNOWN UPCOMING:
Sep25-28/Avid(booth #918): Informa’s BPI’17: BioProcess Intl. Conf. & Exhibition, Boston https://lifesciences.knect365.com/bioprocessinternational
Oct2/NCI Scientist Gregoire Altan-Bonnet(MSKCC ties), AACR’s Tumor Immunotherapy Conf., Boston http://tinyurl.com/y74v76go
...“Long-Lived Disruption of Inflammation Stems from the Catch-and-Release of Cytokines Mediated by Surface Phosphatidylserine in Tumors”
Oct6/Avid(booth): LakePharma Protein Eng. Symposium, So.SanFran http://tinyurl.com/ya6yvetk
~Oct12(??based on 2016): Peregrine's Annual Shareholder’s Meeting (2016 attendee reports: http://tinyurl.com/jx7ouay )
Nov8-12: 32th Annual SITC’17, Natl-Harbor MD http://tinyurl.com/ybfm75wj
...1. PPHM-PrecisionMed: “Results of Epigenetic-Based Quantitative PCR Assisted Immune Cell Counting Analysis in Bavi SUNRISE Trial Subgroup”
...2. MSKCC-PPHM: “PS-Targeting In Combo w/Rad+Immune Checkpoint Blockade Promotes Anti-Tumor Activity in Mouse B16 Melanoma”
Dec11-15/Avid Booth #311: KNect365’s Antibody Eng. & Therapeutics Conf., SanDiego https://lifesciences.knect365.com/antibody-engineering-therapeutics
~Dec11: FY'18Q2 (qe 10-31-17) Financials & Conf. Call - http://ir.peregrineinc.com/events.cfm
Jan18-22 2018: Phacilitate’s Immunotherapy World Forum, Miami http://www.immunotherapyforum.com
...Jan18 12:30-12:45, Joe Shan(VP/Reg+Clin): “Turning up the Heat: PS-Targeting Antibodies Modulate the Tumor Microenvironment & Enhance Checkpoint Blockade”

[BioBS2012]

Alternative Title: How to pet mice and still remain plague free - a study in bleeding shareholders dry.

[north40000]

hutschi and CJG, remembering PPHM's past Chinese connections, this link may be worthwhile exploring/investigating...note particularly ICT's heavy involvement in CAR-T activities, and also remember the new legislation affecting CFDA, Chinese companies and U.S. companies. ICT appears to be one of China's largest biotech companies:

http://www.ictbio.com/

http://in.reuters.com/article/us-china-pharmaceuticals/china-to-accept-overseas-trial-data-in-bid-to-speed-up-drug-approvals-idINKBN1CE080?feedType=RSS&feedName=health&utm_source=Twitter&utm_medium=Social&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29

https://pharmaphorum.com/news/china-accept-overseas-clinical-trial-data/